Could a headband at home keep depression away?

NCT ID NCT07269964

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a portable, at-home brain stimulation device (tDCS) can help people with depression maintain the improvements they achieved during hospital treatment with esketamine, rTMS, or ECT. Thirty adults will use the device for 30 minutes a day, five days a week, for four weeks. The main goal is to see if the home program is feasible and well tolerated, and whether depressive symptoms stay stable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could offer a convenient, home-based way to help people with depression keep their gains after intensive hospital treatment.
What could go wrong
This is a very small, early pilot study (30 people) with no placebo group. It only tests feasibility, not proven effectiveness. The device may cause mild tingling or skin redness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR AFFECTIVE DISORDER (DEPRESSIVE EPISODE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Psychiatry and Psychotherapy, Technical University of Munich, University Hospital

    RECRUITING

    München, 81675, Germany

  • Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich,

    ENROLLING_BY_INVITATION

    München, Bavaria, 81675, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.